Actively Recruiting

Age: 18Years +
All Genders
ID06822205

Identification and Treatment of Renal Stenosis in Transplanted Kidneys

Led by IRCCS Azienda Ospedaliero-Universitaria di Bologna · Updated on 2025-02-12

30

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Renal artery stenosis is a complication that can occur after kidney transplantation, involving narrowing of the artery which may cause symptoms or worsening kidney function. This condition can lead to transplant failure, but the best ways to treat it are still debated. European guidelines recommend endovascular treatment such as angioplasty or stent placement as the first option. The study aims to evaluate the effectiveness and safety of stenting in patients with this condition following kidney transplant. The study includes patients who have undergone endovascular treatment for renal artery stenosis after kidney transplantation. It covers a retrospective phase from January 2020 to April 2023 and a prospective phase starting May 2023 for up to two years. The treatment involves placing stents to open the narrowed artery and improve blood flow to the transplanted kidney. Participants will be monitored for technical success in reducing artery narrowing and for improvements in kidney function over an average period of three years from enrollment. The study tracks complications to assess safety. Patients will have follow-up evaluations to measure these outcomes, contributing to understanding how well stenting works and how safe it is for this condition.

CONDITIONS

Brief Title

Identification and Treatment of Renal Stenosis in Transplanted Kidneys

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age greater than or equal to 18 years
  • Diagnosis of renal artery stenosis in a transplanted kidney
  • Ability to provide informed consent
Not Eligible

You will not qualify if you...

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Monitoring

Duration - Up to 3 years

Participants who have undergone endovascular treatment for renal artery stenosis in transplanted kidneys are observed for efficacy and safety outcomes.

Follow-up visits as per routine clinical care over the observation period

Trial Site Locations

Total: 1 location

1

IRCCS AOU di Bologna Policlinico di Sant'Orsola

Bologna, Italy, 40138

Actively Recruiting

Loading map...

Research Team

M

Mauro Gargiulo, MD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here